bluebird bio (BLUE) Prices 9.09M Share Common Offering at $55/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/3/2026
- Wall Street ends higher as Amazon soothes AI jitters
- Amazon shares rally as cloud growth surges and spending outlook climbs
- Apple shares sink on disappointing September quarter sales outlook
- Novo Nordisk stock tumbles 10% as key trial misses goal
- AI wizkid Leopold Aschenbrenner forced to sell entire portfolio after rout
- SCYNEXIS (SCYX) Move Attributed to Morning Note from Brookline
- AbbVie (ABBV) Misses Q2 EPS by 6c, Beats on Revenue; Offers FY26 EPS Guidance
- Short sellers pile into SpaceX ahead of earnings, lockup expiration
- Wall Street ends higher as Amazon soothes AI jitters
- Novo Nordisk's ziltivekimab fails to reduce heart risk in ZEUS trial
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
- After-Hours Stock Movers: META, MSFT, CMG, SBUX, CVNA, LRCX, FTNT, QCOM, TDOC
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
- After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK
Pre-Open Movers 05/18: (SRNE) (MRNA) (FLGT) Higher; (CTRC) (FSCT) (GSX) Lower (more...)
May 18, 2020 9:26 AM EDTToday's Pre-Open Stock Movers
Centric Brands Inc. (NASDAQ: CTRC) 52.8% LOWER; announced today that it has entered into a Restructuring Support Agreement (RSA or the agreement) with substantially all of the Companys secured lenders, led by certain funds managed by Blackstone (Blackstone), Ares Management Corporation (Ares), and HPS Investment Partners (HPS), to recapitalize the Company, provide $435 million in debtor-in-possession financing and allow the Company to operate without interruption throughout the restructuring process.
Sorrento Therapeutics (NASDAQ: SRNE) 35.5% HIGHER; Adds to Friday's Gain, Up 35%... More
bluebird bio (BLUE) Announces Proposed $400 Million Public Offering of Common Stock
May 18, 2020 7:00 AM EDTbluebird bio, Inc. (Nasdaq: BLUE) today announced that it has commenced an underwritten public offering of $400 million of its common stock. bluebird bio also intends to grant the underwriters a 30-day option to purchase up to an additional fifteen percent (15%) of the... More
